BusinessUpdated 20 min ago
BDR Pharma buys majority stake in oral care biz of Acme Formulation

The transaction values the business at about ₹2,370 crore ($250 million), said sources close to the deal
Continue reading on BusinessLine
Read full story Hello Headlines links you to the original publisher for the full story.




